Format

Send to

Choose Destination
See comment in PubMed Commons below
Arthritis Res Ther. 2004;6(6):279-81. Epub 2004 Oct 15.

What can chronic arthritis pain teach about developing new analgesic drugs?

Author information

1
Center for Drug Evaluation & Research (CDER), FDA, Rockville, Maryland, USA.

Abstract

Chronic pain remains an important public health need with greater impact on the US economy than most other chronic conditions. Current pain management is largely limited to opioids and non-steroidal anti-inflammatory drugs, indicating a gap in the translation of new knowledge to the development of improved pain treatments. Strategies suggested include the re-evaluation of current drug screening methods, a recognition that molecular-genetic events occurring acutely contribute to the development of pain chronicity, the validation of analgesic targets in the intended patient population, consideration of the unique genetic profile that varies between individuals, and the introduction of individual response measures to improve the capture of outcomes in clinical trials.

PMID:
15535840
PMCID:
PMC1064875
DOI:
10.1186/ar1450
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center